/CUPR

CUPR Stock - Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Q: What is the analyst price target for CUPR?

Analyst price target information is not currently available for CUPR.

Q: What is CUPR's market cap?

Market capitalization information is not currently available for CUPR.

Healthcare|Biotechnology|NASDAQ

$0.45-5.83%

$0.03 (-5.83%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.50

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CUPR

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.00

52W High$9.50

52W Low$0.45

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021
Revenue	$48,321	$100,773	$56,599	$58,504
Gross Profit	$-3,024	$36,605	$19,978	$23,057
Gross Margin	-6.3%	36.3%	35.3%	39.4%
Operating Income	$-1,645,259	$-1,068,329	$-1,175,788	$-552,752
Net Income	$-1,560,535	$-1,119,555	$-1,094,516	$-519,686
Net Margin	-3229.5%	-1111.0%	-1933.8%	-888.3%
EPS	$-0.07	$-0.05	$-0.05	$-0.03

Company Overview

Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.

Visit Website

Frequently Asked Questions about CUPR

What is CUPR's current stock price?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) is currently trading at $0.45 per share. The stock has moved -5.83% today.

What is the analyst price target for CUPR?

No analyst price targets are currently available for this stock.

What sector is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares in?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is CUPR's market cap?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares has a market capitalization of $0.01 billion, making it a small-cap company.

Does CUPR pay dividends?

No, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares does not currently pay a dividend to shareholders.